BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31598919)

  • 1. A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Zou B; Yeo YH; Jeong D; Park H; Sheen E; Lee DH; Henry L; Garcia G; Ingelsson E; Cheung R; Nguyen MH
    Dig Dis Sci; 2020 May; 65(5):1520-1528. PubMed ID: 31598919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
    Hirode G; Saab S; Wong RJ
    JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.
    Nguyen AL; Park H; Nguyen P; Sheen E; Kim YA; Nguyen MH
    Dig Dis Sci; 2019 Mar; 64(3):698-707. PubMed ID: 30327963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
    Barritt AS; Jiang Y; Schmidt M; Hayashi PH; Bataller R
    Dig Dis Sci; 2019 Jun; 64(6):1460-1469. PubMed ID: 30673984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
    Kim D; Cholankeril G; Li AA; Kim W; Tighe SP; Hameed B; Kwo PY; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Sep; 39(9):1661-1671. PubMed ID: 31081997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.
    Jang WY; Chung WJ; Jang BK; Hwang JS; Lee HJ; Hwang MJ; Kweon YO; Tak WY; Park SY; Lee SH; Lee CH; Kim BS; Kim SH; Suh JI; Park JG
    J Korean Med Sci; 2020 Jul; 35(29):e233. PubMed ID: 32715667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.).
    Paik JM; Eberly KE; Kabbara K; Harring M; Younossi Y; Henry L; Verma M; Younossi ZM
    Ann Hepatol; 2023; 28(4):101108. PubMed ID: 37088421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing Volume but Decreasing Mortality of Hospitalized Hepatitis C Patients in the United States, 2005 to 2011.
    Luo R; Greenberg A; Stone CD
    J Clin Gastroenterol; 2015 Aug; 49(7):620-7. PubMed ID: 25203363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Hirode G; Vittinghoff E; Wong RJ
    Dig Dis Sci; 2019 Jun; 64(6):1448-1457. PubMed ID: 30863953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease Among Hospitalized Adults in the United States.
    Hirode G; Vittinghoff E; Wong RJ
    J Clin Gastroenterol; 2019; 53(10):765-771. PubMed ID: 31135632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study.
    Axley P; Ahmed Z; Arora S; Haas A; Kuo YF; Kamath PS; Singal AK
    Liver Transpl; 2019 May; 25(5):695-705. PubMed ID: 30861321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
    Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
    BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Maier MM; Zhou XH; Chapko M; Leipertz SL; Wang X; Beste LA
    Dig Dis Sci; 2018 Jun; 63(6):1454-1462. PubMed ID: 29453610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States.
    Allen AM; Kim WR; Moriarty JP; Shah ND; Larson JJ; Kamath PS
    Hepatology; 2016 Dec; 64(6):2165-2172. PubMed ID: 27696493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database.
    Desai AP; Mohan P; Nokes B; Sheth D; Knapp S; Boustani M; Chalasani N; Fallon MB; Calhoun EA
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00062. PubMed ID: 31343469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural History of Cirrhosis: Changing Trends in Etiology Over the Years.
    Idilman R; Aydogan M; Oruncu MB; Kartal A; Elhan AH; Ellik Z; Gumussoy M; Er R; Ozercan M; Duman S; Toruner M; Cinar K; Soykan I; Beyler AR; Ozkan H
    Dig Dis; 2021; 39(4):358-365. PubMed ID: 33142287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide increase in hospitalizations and hepatitis C among inpatients with cirrhosis and sequelae of portal hypertension.
    Nguyen GC; Segev DL; Thuluvath PJ
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1092-9. PubMed ID: 17625983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    Mann JP; Carter P; Armstrong MJ; Abdelaziz HK; Uppal H; Patel B; Chandran S; More R; Newsome PN; Potluri R
    PLoS One; 2020; 15(10):e0241357. PubMed ID: 33108366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy.
    Petta S; Ting J; Saragoni S; Degli Esposti L; Shreay S; Petroni ML; Marchesini G;
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):1014-1022. PubMed ID: 32423665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.